Positive COVID Test? Sign up for a clinical trial.
A number of currently available drugs that may reduce the impact of COVID-19 are being evaluated. The Activ 6 Study is currently enrolling participants, although metformin is not being evaluated. Or check ClinicalTrials.gov for a complete list of clinical trials.
Project Topics
Metformin for COVID
Individuals with diabetes are at higher risk of severe illness from COVID-19 infection. Can tighter control over blood glucose levels make a difference to patients?
A publication by an Italian team provided evidence that COVID-19 patients with hyperglycemia who were treated with insulin infusion had a lower risk of severe disease than patients without insulin infusion. And scientists in China, France, and the U.S. reported that patients with the virus and pre-existing Type 2 diabetes had better outcomes if they had improved glycemic control or were on diabetes medication (metformin), and worse outcomes with uncontrolled hyperglycemia.
Observational studies have suggested a possible benefit of treatment with metformin, a common medication for people with type II diabetes or prediabetes, for COVID-19 outcomes. Scientists have called for more clinical research on metformin and its ability to treat COVID-19 infection. This inexpensive (<$5/month) medication may have antiviral action. Metformin has been used for years off-label to treat other metabolic conditions like obesity, cardiovascular disease, and high blood pressure — the same risk factors for poor outcomes after COVID-19 infection. Metformin is also safe to use during pregnancy.
Metformin lowers blood sugar and inflammation by activating an enzyme called AMPK. This activity also appears to reduce angiotensin-converting enzyme 2 (or ACE2), which serves as a gateway for COVID-19 to enter and infect cells. Thus, the way metformin works to control blood sugar might also help to control coronavirus infection (see this article in Everyday Health).
Randomized controlled studies are needed to know if the survival benefits observed are due to metformin or some other factors. The Together Trial did not find that metformin reduced hospitalizations, but the University of Minnesota COVID-OUT clinical trial evaluating metformin will provide more information.
Take Action
If you recently tested positive for COVID, you can sign up for a clinical trial. Check ClinicalTrials.gov for a complete list of clinical trials.
Additional Resources
Metformin
- Usman A, Bliden KP, Cho A, et al. (2022). Metformin use in patients hospitalized with COVID-19: lower inflammation, oxidative stress, and thrombotic risk markers and better clinical outcomes. J Thromb Thrombolysis. Jan 18 : 1–9. (free full text)
- Reis G, Silva EAM, Silva DCM, et al. Effect of early treatment with metformin on risk of emergency care and hospitalization among patients with COVID-19: The TOGETHER randomized platform clinical trial. Lancet Reg Health Am Feb; 6: 100142. (free full text).
- Ojeda-Fernández L, Foresta A, Macaluso G, et al. (2022). Metformin use is associated with a decrease in the risk of hospitalization and mortality in COVID-19 patients with diabetes: A population-based study in Lombardy. Diabetes Obes Metab. 1–8 (free full text).
- Bramante C, Ingraham N, Murray T, et al. (2021). Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis Lancet Healthy Long 2(1):e34–41. (free full text)
- Ibrahim S, Lowe JR, Bramante CT, et al. (2021). Metformin and Covid-19: Focused review of mechanisms and current literature suggesting benefit. Front. Endocrinol. 12:587801. (free full text).
- Bode B, Garrett V, Messler J, et al. (2020). Glycemic characteristics and clinical outcomes of COVID-19 patients hospitalized in the United States. J Diabetes Sci Technol 14(4):813-821. (free full text)
- Sardu C, D’Onofrio N, Balestrieri ML, et al. (2020). Outcomes in patients with hyperglycemia affected by Covid-19: Can we do more on glycemic control? Diabetes Care 43(7): 1408–1415. (free full text)
- Zhu L, She Z, Cheng X, et al. (2020). Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing Type 2 diabetes. Cell Metabolism 31, 1068–1077. (free full text)
Human Health News
Overused medical tests more common at nonteaching and for-profit hospitals, particularly in the South
In its “Less is More” series of articles, the Journal of the American Medical Association documents the problems of overuse of medical care. “Overused” procedures
Arthritis drug helps fight COVID-19
A medication called baricitinib (brand name Olumiant), which is commonly used to treat rheumatoid arthritis, reduces the risk of death by 13% in hospitalized COVID-19
New idea for laboratory fish enrichment
You might not realize that a small fish is a common model in biomedical research. The zebrafish reproduces quickly and has external fertilization, rapid development,
Overused medical tests more common at nonteaching and for-profit hospitals, particularly in the South
In its “Less is More” series of articles, the Journal of the American Medical Association documents the problems of overuse of medical care. “Overused” procedures
Arthritis drug helps fight COVID-19
A medication called baricitinib (brand name Olumiant), which is commonly used to treat rheumatoid arthritis, reduces the risk of death by 13% in hospitalized COVID-19
New idea for laboratory fish enrichment
You might not realize that a small fish is a common model in biomedical research. The zebrafish reproduces quickly and has external fertilization, rapid development,
Supporting the future of male contraceptive research
The Male Contraceptive Initiative’s Youth Advisory Board recently selected four undergraduate students for awards to fund research in male contraception. The Parsemus Foundation is proud
